Randomized controlled trial of interventions for treatment of shock in children with severe acute malnutrition and cholera or other dehydrating diarrheas

Grant number: 215691/Z/19/Z

Grant search

Key facts

  • Disease

    Cholera
  • Start & end year

    2021
    2025
  • Known Financial Commitments (USD)

    $830,653.02
  • Funder

    Wellcome Trust
  • Principal Investigator

    Dr. Tahmeed Ahmed
  • Research Location

    Bangladesh
  • Lead Research Institution

    International Centre for Diarrhoeal Disease Research, Bangladesh
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Clinical trials for disease management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Children (1 year to 12 years)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Children with severe acute malnutrition and cholera or any other dehydrating diarrhea often present with shock which can be due to either severe dehydration or severe sepsis. While it is challenging to differentiate between severe dehydration and septic shock, more than 40% children with SAM and shock die despite initial intravenous fluid resuscitation. This will be a randomized clinical trial comparing two interventions on children with SAM and shock who do not respond clinically (recovering from shock) to intravenous fluids for resuscitation. The two interventions are dopamine and blood transfusion (recommended by WHO). Although these interventions are practiced in some centres, they are not backed by evidence from RCTs. This proposed RCT will be done in icddr,b Dhaka Hospital that treats 150,000 patients each year with 20% suffering from cholera. The trial, led by icddr,b clinicians and scientists with decades of experience in treating SAM and cholera, will enroll 174 children less than 5 years old with SAM and cholera or any other dehydrating diarrhea plus shock over a period of 2 years. Outcome variables will include rates of case fatality and treatment failure, incidence of heart failure during intervention, need for mechanical ventilation, length of hospitalization, and time-to-achieve recovery.

Publicationslinked via Europe PMC

Efficacy of dopamine, epinephrine and blood transfusion for treatment of fluid refractory shock in children with severe acute malnutrition or severe underweight and cholera or other dehydrating diarrhoeas: protocol for a randomised controlled clinical trial.